These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 25366585

  • 1. Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.
    Ho AS, Wang L, Palmer FL, Yu C, Toset A, Patel S, Kattan MW, Tuttle RM, Ganly I.
    Ann Surg Oncol; 2015 Aug; 22(8):2700-6. PubMed ID: 25366585
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
    Machens A, Lorenz K, Dralle H.
    Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Survival in medullary thyroid carcinoma patients who fail to achieve a biochemical cure: implications of postoperative 1-month calcitonin levels and targeted therapy.
    Song Y, He Y, Kong Z, Peng B, Li H, Ning Y, Song N, Liu S.
    World J Surg Oncol; 2024 Sep 12; 22(1):249. PubMed ID: 39267073
    [Abstract] [Full Text] [Related]

  • 11. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.
    Jayakody S, Reagh J, Bullock M, Aniss A, Clifton-Bligh R, Learoyd D, Robinson B, Delbridge L, Sidhu S, Gill AJ, Sywak M.
    World J Surg; 2018 May 12; 42(5):1432-1439. PubMed ID: 29484475
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
    Samulski TD, Livolsi VA, Montone K, Baloch Z.
    Pathol Res Pract; 2014 Mar 12; 210(3):182-5. PubMed ID: 24440099
    [Abstract] [Full Text] [Related]

  • 14. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR, Fridman TR, Odell MJ, Brierley J, Walfish PG, Freeman JL.
    Laryngoscope; 2005 Aug 12; 115(8):1445-50. PubMed ID: 16094121
    [Abstract] [Full Text] [Related]

  • 15. Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia.
    Ali S, Yu C, Palmer FL, Ganly I, Shaha A, Shah JP, Kattan MW, Patel SG.
    Arch Otolaryngol Head Neck Surg; 2011 Nov 12; 137(11):1154-60. PubMed ID: 22106243
    [Abstract] [Full Text] [Related]

  • 16. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma.
    Cote GJ, Evers C, Hu MI, Grubbs EG, Williams MD, Hai T, Duose DY, Houston MR, Bui JH, Mehrotra M, Waguespack SG, Busaidy NL, Cabanillas ME, Habra MA, Luthra R, Sherman SI.
    J Clin Endocrinol Metab; 2017 Sep 01; 102(9):3591-3599. PubMed ID: 28911154
    [Abstract] [Full Text] [Related]

  • 17. Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin.
    Zhou Q, Yue S, Cheng Y, Jin J, Xu H.
    Exp Toxicol Pathol; 2017 Oct 02; 69(8):575-579. PubMed ID: 28552629
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F, Frank-Raue K.
    Recent Results Cancer Res; 2015 Oct 02; 204():207-25. PubMed ID: 26494391
    [Abstract] [Full Text] [Related]

  • 19. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy.
    Kwon H, Kim WG, Jeon MJ, Song DE, Lee YM, Sung TY, Chung KW, Yoon JH, Hong SJ, Baek JH, Lee JH, Kim TY, Kim WB, Shong YK.
    Endocrine; 2016 Jul 02; 53(1):174-81. PubMed ID: 26754662
    [Abstract] [Full Text] [Related]

  • 20. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
    Kuo EJ, Sho S, Li N, Zanocco KA, Yeh MW, Livhits MJ.
    JAMA Surg; 2018 Jan 01; 153(1):52-59. PubMed ID: 28973144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.